News: August, 2010

« Previous Page

Study Gives Insights into DNA Replication

Friday, August 13th, 2010

Like a lawn mower engine that needs to be “primed” before it can be started, the molecular machinery that copies DNA needs a push too. Vanderbilt University investigators have now determined the structure of a critical piece of human DNA primase — the protein that gets DNA replication going. The findings, reported in the Aug. [...]

Join Team Vanderbilt for Race for the Cure

Tuesday, August 10th, 2010

Vanderbilt-Ingram Cancer Center will sponsor the 19th annual Greater Nashville Race for the Cure, an awareness- and fund-raiser for  Komen for a Cure, and will field Team Vanderbilt, a team of walkers and runners representing the entire Vanderbilt University community. Last year, Team Vanderbilt won the largest health care team award, with 340 registered participants, [...]

Malcolm Named Radiation Oncology Chair

Friday, August 6th, 2010

Following an intensive appointment process, Arnold Malcolm, M.D., has been named chair of Vanderbilt’s Department of Radiation Oncology. Malcolm has served as interim chair since May 2009 following the departure of Dennis Hallahan, M.D. “Arnold Malcolm represents the best and brightest in the field of Radiation Oncology,” said Jeff Balser, M.D., Ph.D., vice chancellor for [...]

Prognostic Marker for Gastric Cancer

Friday, August 6th, 2010

While chemotherapy is recommended for advanced gastric cancer, there are no clear criteria for adjuvant chemotherapy in early stage gastric cancer. To identify potential biomarkers that could help select candidates for chemotherapy, James Goldenring, M.D., Ph.D, Ki Taek Nam, DVM, Ph.D., and colleagues at Seoul National University, examined gene expression in lesions from patients with [...]

American Chemical Society Honors Marnett

Friday, August 6th, 2010

Vanderbilt University’s Lawrence Marnett, Ph.D., has been named to the second class of American Chemical Society Fellows in recognition of his “outstanding contributions” to chemistry and the ACS. Marnett, the Mary Geddes Stahlman Professor of Cancer Research and professor of Biochemistry and Chemistry, is among 192 fellows named this year by the ACS, the world’s [...]

VICC Launches Genome-Driven Therapy

Wednesday, August 4th, 2010

Vanderbilt-Ingram Cancer Center (VICC) has launched its new Personalized Cancer Medicine Initiative, becoming the first cancer center in the Southeast and one of the first in the nation to offer adult cancer patients routine “genotyping” of their tumors at the DNA level. This information will then be used to personalize treatment by matching the appropriate [...]